| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 02/17/2005 | WO2005013932A1 Use of spermine and/or spermidine against skin ageting in dietary, pharmaceutical or cosmetic compositions |
| 02/17/2005 | WO2005013897A2 Magnetic nanoparticle compositions, and methods related thereto |
| 02/17/2005 | WO2005013724A1 Aiding of cognitive function |
| 02/17/2005 | WO2004091435A3 Osteoinductive bone material |
| 02/17/2005 | US20050038018 Meloxicam compositions |
| 02/17/2005 | US20050038008 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 02/17/2005 | US20050037998 Enhancement of magnesium uptake in mammals |
| 02/17/2005 | US20050037996 Controlling temperature and pH while complexing |
| 02/17/2005 | US20050037948 Calcium phosphopeptide complexes |
| 02/17/2005 | US20050037093 Treatment of nail infections with no |
| 02/17/2005 | US20050037092 Vascularization therapy by highly concentrated carbonated warm water bath |
| 02/17/2005 | US20050037091 Composition comprising paracetamol and a bitterness masking component |
| 02/17/2005 | US20050037090 Selected from Vitaxin, exemestane, anastrozole, letrozole, thiotepa, SU-5416, capecitabine, tamoxifen, raloxifene, fluoxymesterone, megestrol, toremifene, goserelin, ornithine decarboxylase inhibitors such as eflornithine, bisphosphonates and sulindac sulfone |
| 02/17/2005 | US20050037089 Administering a bone remodeling agent such as parathyroid hormone and a dietary supplement comprising calcium and phosphorus |
| 02/17/2005 | US20050037070 Acid labile proton pump inhibitor microencapsulated with material that enhances shelf-life of pharmaceutical formulation, and antacid, wherein initial serum concentration of proton pump inhibitor is greater than 0.1 mu g/ml at any time within 30 minutes after administration of pharmaceutical; shelf life |
| 02/17/2005 | US20050037065 Fatty acids from both plant and animal sources and methods for minimizing unpleasant taste, regurgitation, gastroesophageal reflux, dyspepsia, nausea, or difficulty in swallowing or ingesting; for pregnant or lactating women |
| 02/17/2005 | US20050037058 Method for producing a silver-containing wound care device |
| 02/17/2005 | US20050037057 silver zirconium phosphate coated wound care device exhibits a controlled silver-ion release rate of less than about 25 mu g/cm2 of silver ions over a 24 hour period, and wherein said finish exhibits antimicrobial properties |
| 02/17/2005 | US20050037054 Gloves containing dry powdered Aloe and method of manufacturing |
| 02/17/2005 | US20050037034 mixture of carriers, abrasive particles and antiacne agents; exfoliation of human skins using applicators having handles and motors |
| 02/17/2005 | US20050037026 such as Alzheimer's disease; amyloid precursor proteins; comprises diphtheria toxoid as carrier |
| 02/17/2005 | US20050036949 A pharmaceutical dispenser; a liquid formulation comprising nitric oxide; respiratory system diseases; atomizing |
| 02/17/2005 | US20050035177 Method for preparing colloidal solution of bismuth sodium tartrate |
| 02/17/2005 | DE202004012980U1 Nasal spray for removing germs and dirt particles from the nose contains a Himalayan salt sol containing sodium chloride and a further eighty-four elements of the periodic table |
| 02/17/2005 | DE10332011A1 Verwendung von Glaszusammensetzungen zum Erzielen eines antioxidativen Effektes Use of glass compositions to achieve an anti-oxidative effect |
| 02/17/2005 | DE10329925A1 Side-effect free inhalation anesthetic, especially useful in intensive care patients, comprises gaseous xenon, optionally in combination with organic hypnotic agents |
| 02/17/2005 | CA2535506A1 Pharmaceutical compositions for preventing breast and ovarian cancer |
| 02/17/2005 | CA2535448A1 Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions |
| 02/17/2005 | CA2534687A1 Magnetic nanoparticle compositions, and methods related thereto |
| 02/17/2005 | CA2534157A1 Viscosity-stable bismuth-containing pharmaceutical compositions |
| 02/17/2005 | CA2534102A1 Use of spermine and/or spermidine against skin ageing in dietary, pharmaceutical or cosmetic compositions |
| 02/17/2005 | CA2532344A1 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases |
| 02/16/2005 | EP1507005A2 Antisense modulation of BCL-X expression |
| 02/16/2005 | EP1506784A1 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/16/2005 | EP1506781A1 Vaginal care composition |
| 02/16/2005 | EP1506755A2 Patient temperature regulation apparatus |
| 02/16/2005 | EP1506237A1 Treatment of cancer by the use of anti fas antibody |
| 02/16/2005 | EP1505990A2 Methods of treating hepatitis |
| 02/16/2005 | EP1505988A1 Dual dispenser for aesthetically acceptable delivery of anhydrous skin treatment compositions |
| 02/16/2005 | EP1425582A4 Diagnostic markers for ischemia |
| 02/16/2005 | EP1339417B1 Preparation for the treatment of surface open wounds |
| 02/16/2005 | CN2678648Y Bone protecting calcium tablet |
| 02/16/2005 | CN1582157A Rehydrating formulation |
| 02/16/2005 | CN1582152A composition of estrogen and other hormons with ascorbate, lysine, proline and other substances |
| 02/16/2005 | CN1579549A Composition medicine for curing acute early-young granulocytic leukemia |
| 02/16/2005 | CN1579473A Medicine composition for treating stomach disease, its preparation method and use |
| 02/16/2005 | CN1579419A Medicine composition with synergistic function for treating chronic granulocytic leukemia |
| 02/16/2005 | CN1579418A Preparation pixuanjing for treating psoriasis and its preparation method |
| 02/16/2005 | CN1579417A Compound dewatered diuretic medicinal composition and its preparation method |
| 02/16/2005 | CN1579416A Medicinal composition for treating liver disease, its prepration method and use |
| 02/16/2005 | CN1189217C Ending vascular embolism preparation |
| 02/16/2005 | CN1189201C Externally applied Chinese medicine for treating osteoarthropathy and its prepn process |
| 02/16/2005 | CN1189195C Medicine for curing cough and asthma |
| 02/16/2005 | CN1189193C Ointment for treating burn |
| 02/16/2005 | CN1189192C Chiense medicine for treating bone fracture |
| 02/16/2005 | CN1189188C Leukoderma curing plaster |
| 02/16/2005 | CN1189182C Application of nano copper powder in preparation of antisenility medicine |
| 02/16/2005 | CN1189181C Arsenic trioxide (ATO) oral slow-releasing granules and its preparation method |
| 02/16/2005 | CN1189180C Bicarbonate dry powder composition for hemodialysis |
| 02/16/2005 | CN1189179C Capsule for treating hepatosis and its preparation |
| 02/16/2005 | CN1189155C Dual component tooth whitening dentifrice |
| 02/15/2005 | US6855342 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 02/15/2005 | US6855341 zinc compound and at least one phenolic antioxidant and a pharmaceutical carrier. |
| 02/15/2005 | US6855340 Administering an agent that binds or complexes copper such as ammonium tetrathiomolybdate |
| 02/15/2005 | US6855339 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 02/15/2005 | US6855328 Antimicrobial and antiviral compositions containing an oxidizing species |
| 02/15/2005 | US6855325 Preventing and limiting release of chemical mediators responsible for initiating cutaneous inflammation; cosmetics |
| 02/12/2005 | CA2437258A1 A method of inducing pulmonary dilation of a bird with gaseous nitric oxide |
| 02/10/2005 | WO2005011734A2 Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer |
| 02/10/2005 | WO2005011711A2 Inhalable gaseous medicine based on xenon and nitrous oxide |
| 02/10/2005 | WO2005011639A2 Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use |
| 02/10/2005 | WO2005011575A2 Stabilization and ionic triggering of nitric oxide release |
| 02/10/2005 | WO2005011570A2 Calcium carbonate granulation |
| 02/10/2005 | WO2005011400A1 Supplement preparation |
| 02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 02/10/2005 | US20050033081 Treating an animal for parasites |
| 02/10/2005 | US20050033026 Immunoconjugates for the treatment of tumours |
| 02/10/2005 | US20050032914 Lutein/zeaxanthin for glare protection |
| 02/10/2005 | US20050032801 Compositions containing a ruthenium(III) complex and a heterocycle |
| 02/10/2005 | US20050032741 Vitamin Compositions |
| 02/10/2005 | US20050032740 Vitamin B12, vitamin B6, folic acid, magnesium, and vitamin E; anticholesterol agents |
| 02/10/2005 | US20050032715 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 02/10/2005 | US20050032699 Composition of a VEGF antagonist and an anti-proliferative agent |
| 02/10/2005 | US20050032698 includes a divalent cation (zinc chloride) in an amount effective to stabilize the hormone; osteoporosis |
| 02/10/2005 | US20050031708 Composition comprising a zeolite compound for treatment of diseases |
| 02/10/2005 | US20050031707 A solution in water of sodium ions in major amount and potassium ions in minor amount, together with physiologically acceptable counter ions, being isotonic, free of calcium ions, magnesium ions, phosphate ions, bicarbonate ions and glucose, sucrose, food starch; cell friendly |
| 02/10/2005 | US20050031706 A bismuth containing agent , a non-clay-derived suspending agent; an stabilizer for reducing viscosity change during storage of the formulation and water |
| 02/10/2005 | US20050031705 Topical veterinary compositions and methods for the treatment and prevention of infection |
| 02/10/2005 | US20050031704 Tricalcium phosphates, their composites, implants incorporating them, and method for their production |
| 02/10/2005 | US20050031702 Application of arsenic as a cancer and heart disease prevention agent |
| 02/10/2005 | US20050031700 In the form of a powder for suspension containing (a) an acid-labile proton pump inhibitor in micronized from; b) an antacid; and c) a gum as suspending agent |
| 02/10/2005 | US20050031685 Pharmaceutical composition for controlled release of a beta-lactam antibiotic |
| 02/10/2005 | US20050031679 Method for producing liposomal formulations of active ingredients |
| 02/10/2005 | US20050031629 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 02/10/2005 | US20050031523 titrating an aqueous slurry of sodium zirconium carbonate to a pH of 3.5 to about 4.0 with a acidic agent,and washing the zirconium basic carbonate with water; renal dialysis applications and chemical intermediates |
| 02/10/2005 | DE202004018579U1 Ointment or cream composition for treating skin diseases, especially neurodermatitis, comprises sulfur dispersed in a fat-containing ointment base |
| 02/10/2005 | CA2769570A1 Calcium carbonate granulation |
| 02/10/2005 | CA2716449A1 Calcium carbonate granulation |
| 02/10/2005 | CA2533499A1 Inhalable gaseous medicine based on xenon and nitrous oxide |
| 02/10/2005 | CA2532883A1 Supplement preparation |